Dihydrobiopterin is used in management of which amino acid defect?
**Core Concept**
Dihydrobiopterin (BH2) is a reduced form of tetrahydrobiopterin (BH4), a crucial cofactor for enzymes involved in amino acid metabolism, particularly phenylalanine hydroxylase. This cofactor plays a vital role in the hydroxylation of phenylalanine to tyrosine.
**Why the Correct Answer is Right**
BH2 is used to manage Phenylketonuria (PKU), a genetic disorder caused by a deficiency of phenylalanine hydroxylase, the enzyme responsible for converting phenylalanine to tyrosine. In PKU patients, the enzyme is unable to convert phenylalanine to tyrosine due to the absence of BH4, leading to the accumulation of phenylalanine in the body. BH2 supplementation can help restore the activity of phenylalanine hydroxylase and reduce phenylalanine levels.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because dihydrobiopterin is not used in the management of Maple Syrup Urine Disease (MSUD), a disorder of branched-chain amino acid metabolism.
**Option B:** This option is incorrect because dihydrobiopterin is not used in the management of Homocystinuria, a disorder of methionine metabolism.
**Option C:** This option is incorrect because dihydrobiopterin is not used in the management of Albinism, a disorder of melanin production.
**Clinical Pearl / High-Yield Fact**
BH4 deficiency can also affect other enzymes, such as tyrosine hydroxylase, which is involved in the production of dopamine and norepinephrine. This can lead to neurological symptoms in some patients with BH4 deficiency.
**Correct Answer: A. Phenylketonuria (PKU).**